Office of AIDS
Access to Sterile Syringes in California
People who inject drugs continue to be at risk for HIV and hepatitis C (HCV) infection in California. Injection drug use is a risk factor linked to 14.8 percent of all living HIV/AIDS cases in the state, and to the majority of new cases of HCV. Research has consistently found that increasing access to sterile syringes significantly reduces the risk of HIV transmission.
California law supports public health efforts to expand access to sterile syringes through both syringe exchange programs (SEPs) and nonprescription syringe sale in pharmacies. To find a syringe exchange program near you, download the Directory of California SEPs below under Quick Links. Information for pharmacy customers is available on the Information for Customers page of this web site. For further information about nonprescription syringe sale contact Alessandra Ross, Injection Drug Use Specialist at 916-449-5796 or firstname.lastname@example.org.
Authorized syringe exchange programs interested in receiving supplies from the California Syringe Exchange Supply Clearinghouse can request an application from NASEN by emailing Shantel Davis at Shantel@nasen.org.